Eugene Schneider, EVP, Chf Clinical Develop Ofcr at IONIS PHARMACEUTICALS INC (IONS), sold 8,000 shares at $53.50 ($428K) on 2024-01-12, disclosed to the SEC on 2024-01-17.
Scheduled sale ($428k) by EVP, Chf Clinical Develop Ofcr under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| IONS | SELL | 2026-02-02 | $516K | — | Filing → |
| IONS | SELL | 2026-01-20 | $703K | — | Filing → |
| IONS | SELL | 2025-09-04 | $2.4M | — | Filing → |